Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S5. (a-e) µCT-based monitoring of KPE and KPE post cis allograft tumor response in KPE syngeneic mice (n = 4) prior to and after etoposide treatment (Mice 2-5 shown). Allograft tumors are marked with "T".
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S3. Anti-Ercc1 immunostaining of lung sections of KPE mice (n = 8) after cisplatin treatment shown at different magnifications.
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S4. (a) Representative immunostaining of Pt-(GpG) adducts in KP and KPE cell lines after cisplatin exposure (left). Quantification of Pt-(GpG) adduct staining in KP (n = 5) and KPE (n = 6) cells after cisplatin exposure (right). P values were calculated using …
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S1.(a) Distribution of tumor vs. normal lung tissue in K, KE, KP and KPE mice at 4 weeks post tumor induction (top). Distribution of murine lung adenocarcinoma grades (G1, G2, G3) in corresponding K, KE, KP and KPE mice at 4 weeks …
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S2.(a) µCT-based monitoring of tumor response in K and KE mice prior to and after cisplatin treatment (left). Quantification of tumor volume in K and KE mice prior to and after cisplatin treatment (right). P values were calculated using two-tailed t-test. (b) …
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S2.(a) µCT-based monitoring of tumor response in K and KE mice prior to and after cisplatin treatment (left). Quantification of tumor volume in K and KE mice prior to and after cisplatin treatment (right). P values were calculated using two-tailed t-test. (b) …
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S3. Anti-Ercc1 immunostaining of lung sections of KPE mice (n = 8) after cisplatin treatment shown at different magnifications.
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S1.(a) Distribution of tumor vs. normal lung tissue in K, KE, KP and KPE mice at 4 weeks post tumor induction (top). Distribution of murine lung adenocarcinoma grades (G1, G2, G3) in corresponding K, KE, KP and KPE mice at 4 weeks …
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S4. (a) Representative immunostaining of Pt-(GpG) adducts in KP and KPE cell lines after cisplatin exposure (left). Quantification of Pt-(GpG) adduct staining in KP (n = 5) and KPE (n = 6) cells after cisplatin exposure (right). P values were calculated using …
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
S5. (a-e) µCT-based monitoring of KPE and KPE post cis allograft tumor response in KPE syngeneic mice (n = 4) prior to and after etoposide treatment (Mice 2-5 shown). Allograft tumors are marked with "T".
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
Abstract KRAS-mutant lung adenocarcinoma is among the most common cancer entities and, in advanced stages, typically displays poor prognosis due to acquired resistance against chemotherapy, which is still largely based on cisplatin-containing combination regimens. Mechanisms of cisplatin resistance have been extensively investigated, …
Accès ouvert
2023
other
OpenAlex
Mladen Jokić, Ignacija Vlašić, Miriam Rinneburger, Niklas Klümper et autres
Abstract KRAS-mutant lung adenocarcinoma is among the most common cancer entities and, in advanced stages, typically displays poor prognosis due to acquired resistance against chemotherapy, which is still largely based on cisplatin-containing combination regimens. Mechanisms of cisplatin resistance have been extensively investigated, …